Remazolbrilliant Blue covalently linked to amylose (Amylose Azure) has been used for the determination of ex-amylase (Rinderknecht, Wild-ing, and Haverback, 1967) . It forms an insoluble suspension in aqueous media, but liberates a soluble highly coloured blue dye as a result of amylase activity. This communication describes the use of this compound for the demonstration of amylase isoenzymes separated on cellulose acetate membranes.
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Materials and Methods
Pancreatic homogenates, saliva, urine, and sera were separated on cellulose acetate membrane. Pancreatic extracts and saliva were diluted with serum of very low amylase activity (less than 60 Somogyi units) to yield activities of approximately 1,000 Somogyi units.
Cellulose acetate separations were carried out using Oxoid cellulose acetate membranes or the Beckman microzone system. For the former, cellulose acetate membranes, 12 x 5 cm, were used and the sample applied 2 cm to the anode side of the midline using an 8 cm bridge gap. Separations were carried out at 4°C using barbitone buffer, pH 8 6, ,u 0-07, at a constant voltage of 200 V for two hours.
Using the Beckman microzone system, samples were applied at the slots nearest to the anode side of the midline. For tissue extracts, one application (0-25 ,ul) (Fig. 2) , the most prominent of which occupied a position corresponding to the pancreatic isoamylase. In sera showing raised amylase activity from patients with mumps parotitis, isoamylase corresponding in mobility to that of the salivary enzyme could be demonstrated (Fig. 2) . These results were in accord with findings obtained by other separation and isoenzyme demonstration methods (Kamaryt and Laxova, 1965 ; Hobbs and Aw,1 968); subcomponents of the isoamylases were not resolved.
Comment
Electrophoretically separated isoamylases may be demonstrated by a variety of methods. However, elution and saccharogenic assay is somewhat tedious; staining techniques utilizing the starch-iodine reaction are subject to interference by protein, and a coupled-enzyme staining technique used for demonstrating maltose formed from starch (Joseph, Olivero, and Ressler, 1966) is somewhat non-specific (Hobbs and Aw, 1968 They recommend that venous blood is anticoagulated with one tenth its volume of 3-8% sodium citrate. In their eventual calculation of the fibrinogen result they include a correction factor of 10/9 for anticoagulant dilution. This of course is wrong because, first, the plasma dilution by anticoagulant is much more, and secondly their calculation ignores variations in haematocrit. The significance of these criticisms may be illustrated by the following examples:
Let (a) 4-5'ml blood be anticoagulated with 0 5 ml 3-8 % sodium citrate and, (b) the plasma (+citrate) fibrinogen as measured by the method be 250 mg%. Using their factor 10/9 this would give a corrected fibrinogen concentration of 278 mg%.
The following calculations show the results in three examples where the packed cell volume is 40 %, 50 %, and 60 % respectively, assuming, of course, that citrate dilutes the plasma only. 1 PCV40% Fig. 1 
